No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: A prospective, randomized, multicenter study

Transplantation

Volumn 78, Issue 1, 2004, Pages 101-106

  Ter Meulen, Cornelis G ^a   Van Riemsdijk, Iza ^b   Hené, Ronald J ^c   Christiaans, Maarten H L ^d   Borm, George F ^a   Corstens, Frans H M ^a   Van Gelder, Teun ^b   Hilbrands, Luuk B ^a   Weimar, Willem ^b   Hoitsma, Andries J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Complications of clinical transplantation; Corticosteroids; Daclizumab; Immunosuppression; Monoclonal antibodies; Tacrolimus

Indexed keywords

CALCIUM; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE MASS; BONE MINERAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EXPOSURE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OSTEOLYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE DENSITY; CALCIUM; CREATININE; FEMALE; FEMORAL NECK FRACTURES; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHORUS; POSTOPERATIVE COMPLICATIONS; PREDNISONE; PROSPECTIVE STUDIES;

EID: 4143113642     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000133513.29923.44     Document Type: Article

References (36)

1. Ramsey-Goldman R, Dunn JE, Dunlop DD, et al. Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 1999; 14: 456.
2. Ball AM, Gillen DL, Sherrard D, et al. Risk of hip fracture among dialysis and renal transplant recipients. JAMA 2002; 288: 3014.
3. Grotz WH, Mundinger FA, Gugel B, et al. Bone fracture and osteodensitometry with dual energy X-ray absorptiometry in kidney transplant recipients. Transplantation 1994; 58: 912.
4. Parker CR, Freemont AJ, Blackwell PJ, et al. Cross-sectional analysis of renal transplantation osteoporosis. J Bone Miner Res 1999; 14: 1943.
5. Abbott KC, Oglesby RJ, Hypolite IO, et al. Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol 2001; 11: 450.
6. De Sevaux RG, Hoitsma AJ, van Hoof HJ, et al. Abnormal vitamin D metabolism and loss of bone mass after renal transplantation. Nephron Clin Pract 2003; 93: C21.
7. De Sevaux RG, Hoitsma AJ, Corstens FH, et al. Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol 2002; 13: 1608.
8. Julian BA, Laskow DA, Dubovsky J, et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544.
9. Almond MK, Kwan JT, Evans K, et al. Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 1994; 66:52.
10. Mikuls TR, Julian BA, Bartolucci A, et al. Bone mineral density changes within six months of renal transplantation. Transplantation 2003; 75: 49.
11. Horber FF, Casez JP, Steiger U, et al. Changes in bone mass early after kidney transplantation. J Bone Miner Res 1994; 9: 1.
12. Grotz WH, Mundinger FA, Rasenack J, et al. Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 1995; 10: 2096.
13. Carlini RG, Rojas E, Weisinger JR, et al. Bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis 2000; 36: 160.
14. Wolpaw T, Deal CL, Fleming-Brooks S, et al. Factors influencing vertebral bone density after renal transplantation. Transplantation 1994; 58: 1186.
15. Pichette V, Bonnardeaux A, Prudhomme L, et al. Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 1996; 28: 105.
16. Aroldi A, Tarantino A, Montagnino G, et al. Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study. Transplantation 1997; 63: 380.
17. Cole E, Landsberg D, Russell D, et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001; 72: 845.
18. Laan RF, van Riel PL, van de Putte LB, et al. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med 1993; 119: 963.
19. Mart G, Gomez R, Jodar E, et al. Long-term follow-up of bone mass after orthotopic liver transplantation: effect of steroid withdrawal from the immunosuppressive regimen. Osteoporos Int 2002; 13: 147.
20. ter Meulen CG, Riemsdijk-van Overbeeke IC, Hene RJ, et al. Steroid-withdrawal at three days after transplantation with anti-IL-2 receptor alpha therapy. A prospective randomized multicenter study. Am J Transplantation 2004; 4: 803.
21. Faulkner KG, McClung MR. Quality control of DXA instruments in multicenter trials. Osteoporos Int 1995; 5: 218.
22. Genant HK, Grampp S, Gluer CC, et al. Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 1994; 9: 1503.
23. Payne RB, Little AJ, Williams RB, et al. Interpretation of serum calcium in patients with abnormal serum proteins. BMJ 1973; 4: 643.
24. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
25. Van Den Ham EH, Kooman JP, Christiaans ML, et al. The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients. Transpl Int 2003; 16: 82.
26. Heaf JG. Bone disease after renal transplantation. Transplantation 2003; 75: 315.
27. Schwid SR, Goodman AD, Puzas JE, et al. Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis. Arch Neurol 1996; 53: 753.
28. Coffin E, Devogelaer JP, Depresseux G, et al. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study. Clin Nephrol 2003; 59: 190.
29. Fan SL, Almond MK, Ball E, et al. Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 2000; 57: 684.
30. Grotz W, Nagel C, Poeschel D, et al. Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 2001; 12: 1530.
31. Coco M, Glicklich D, Faugere MC, et al. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 2003; 14: 2669.
32. Weber TJ, Quarles LD. Preventing bone loss after renal transplantation with bisphosphonates: we can, but should we? Kidney Int 2000; 57: 735.
33. Inoue T, Kawamura I, Matsuo M, et al. Lesser reduction in bone mineral density by the immunosuppressant, FK506, compared with cyclosporine in rats. Transplantation 2000; 70: 774.
34. Cvetkovic M, Mann GN, Romero DF, et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 1994; 57: 1231.
35. El Haggan W, Barthe N, Vendrely B, et al. One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine. Transplant Proc 2002; 34: 1817.
36. Njeh CF, Fuerst T, Diessel E, et al. Is quantitative ultrasound dependent on bone structure? A reflection. Osteoporos Int 2001; 12: 1.